dc.creatorGómez Sánchez, Eduardo
dc.creatorFranco de la Torre, Lorenzo
dc.creatorHernández Gómez, Adriana
dc.creatorAlonso Castro, Ángel Josabad
dc.creatorSerafín Higuera, Nicolás
dc.creatorTerán Rosales, Flavio
dc.creatorBologna Molina, Ronell Eduardo
dc.creatorIsiordia Espinoza, Mario Alberto
dc.date2023-02-08T18:32:12Z
dc.date2023-02-08T18:32:12Z
dc.date2023-02
dc.date.accessioned2023-07-21T21:46:11Z
dc.date.available2023-07-21T21:46:11Z
dc.identifierGómez-Sánchez, E, Franco-de la Torre, L, Hernández-Gómez, A, et al. Antagonistic, synergistic, and additive antibacterial interaction between ciprofloxacin and amoxicillin against Staphylococcus aureus. Fundam Clin Pharmacol. 2023; 37( 1): 174- 181. doi:10.1111/fcp.12832
dc.identifier1472-8206 online
dc.identifier0767-3981 print
dc.identifierdoi:10.1111/fcp.12832
dc.identifierhttp://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1461
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7752929
dc.descriptionArtículo
dc.descriptionAbstractThe aim of this in vitro study was to evaluate the interaction between ciprofloxacin and amoxicillin against beta-lactamase-producing Staphylococcus aureus. Concentration-dependent curves for each individual drug were carried out to obtain the mean inhibitory concentration in the agar well diffusion assay. Then, different ratios of the ciprofloxacin–amoxicillin combination (0.5:0.5, 0.8:0.2, 0.2:0.8, 0.9:0.1, 0.1:0.9, 0.95:0.05, and 0.05:0.95) were assessed. Data were analyzed using the isobolographic analysis and interaction index. The isobolographic evaluation shows that the 0.9:0.1 and 0.95:0.05 ratios of the ciprofloxacin–amoxicillin combination produced a synergistic antimicrobial interaction, the 0.8:0.2, 0.2:0.8, 0.1:0.9, and 0.05:0.95 proportions showed an additive antibacterial effect, and the 0.5:0.5 proportion induced antagonistic antimicrobial effects. The interaction index showed similar outcomes to the isobolographic analysis. In conclusion, the data of this study mainly show antimicrobial additive results of the ciprofloxacin–amoxicillin combination against beta-lactamase-producing S. aureus.
dc.languageen
dc.publisherJohn Wiley & Sons, Ltd
dc.relationFundamental & Clinical Pharmacology;Volume 37, Issue 1
dc.subjectamoxicillin
dc.subjectantimicrobial interaction
dc.subjectciprofloxacin
dc.subjectStaphylococcus aureus
dc.titleAntagonistic, synergistic, and additive antibacterialinteraction between ciprofloxacin and amoxicillin againstStaphylococcusaureus
dc.typeArticle


Este ítem pertenece a la siguiente institución